ClinVar Miner

Submissions for variant NM_007294.3(BRCA1):c.2868del (p.Gln957fs) (rs80357929)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Breast Cancer Information Core (BIC) (BRCA1) RCV000111952 SCV000144565 pathogenic Breast-ovarian cancer, familial 1 2001-10-29 no assertion criteria provided clinical testing
Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), c/o University of Cambridge RCV000111952 SCV000325484 pathogenic Breast-ovarian cancer, familial 1 2015-10-02 criteria provided, single submitter clinical testing
Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) RCV000111952 SCV000299846 pathogenic Breast-ovarian cancer, familial 1 2016-09-08 reviewed by expert panel curation Variant allele predicted to encode a truncated non-functional protein.
Integrated Genetics/Laboratory Corporation of America RCV000590751 SCV000698983 pathogenic Hereditary breast and ovarian cancer syndrome 2017-06-22 criteria provided, single submitter clinical testing Variant summary: The BRCA1 c.2868delT (p.Gln957Serfs) variant results in a premature termination codon, predicted to cause a truncated or absent BRCA1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. p.Arg1751X, p.Gln1779X, p.Ser1796X, etc.). This variant is absent in 121346 control chromosomes from ExAC. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. This variant has been reported in at least two HBOC patients in literature (Judkins_2005, Shirts_2016). Taken together, this variant is classified as pathogenic.
University of Washington Department of Laboratory Medicine,University of Washington RCV000111952 SCV000266029 pathogenic Breast-ovarian cancer, familial 1 2015-11-20 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.